Metabolic effects of anti-angiogenic therapy in tumors

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Anti-angiogenic therapy has recently been added to the panel of cancer therapeutics, but predictive biomarkers of response are still not available. In animal models, anti-angiogenic therapy causes tumor starvation by increasing hypoxia and impairing nutrients supply. It is thus conceivable that angiogenesis inhibition causes remarkable metabolic perturbations in tumors, although they remain largely uncharted. We review here recent acquisitions about metabolic effects of angiogenesis blockade in tumors and discuss the possibility that some metabolic features of tumor cells - i.e. their dependency from glucose as primary energy substrate - might affect tumor responses to anti-VEGF treatment.

Original languageEnglish
Pages (from-to)925-931
Number of pages7
JournalBiochimie
Volume94
Issue number4
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Tumors
Neoplasms
Therapeutics
Biomarkers
Vascular Endothelial Growth Factor A
Nutrients
Starvation
Animals
Cells
Animal Models
Glucose
Food
Substrates

Keywords

  • Angiogenesis
  • Anti-angiogenic therapy
  • Glycolysis
  • LKB1-AMPK pathway

ASJC Scopus subject areas

  • Biochemistry

Cite this

Metabolic effects of anti-angiogenic therapy in tumors. / Zulato, Elisabetta; Curtarello, Matteo; Nardo, Giorgia; Indraccolo, Stefano.

In: Biochimie, Vol. 94, No. 4, 04.2012, p. 925-931.

Research output: Contribution to journalArticle

@article{e76e8f770da74854a9bd38ce21466a22,
title = "Metabolic effects of anti-angiogenic therapy in tumors",
abstract = "Anti-angiogenic therapy has recently been added to the panel of cancer therapeutics, but predictive biomarkers of response are still not available. In animal models, anti-angiogenic therapy causes tumor starvation by increasing hypoxia and impairing nutrients supply. It is thus conceivable that angiogenesis inhibition causes remarkable metabolic perturbations in tumors, although they remain largely uncharted. We review here recent acquisitions about metabolic effects of angiogenesis blockade in tumors and discuss the possibility that some metabolic features of tumor cells - i.e. their dependency from glucose as primary energy substrate - might affect tumor responses to anti-VEGF treatment.",
keywords = "Angiogenesis, Anti-angiogenic therapy, Glycolysis, LKB1-AMPK pathway",
author = "Elisabetta Zulato and Matteo Curtarello and Giorgia Nardo and Stefano Indraccolo",
year = "2012",
month = "4",
doi = "10.1016/j.biochi.2012.01.001",
language = "English",
volume = "94",
pages = "925--931",
journal = "Biochimie",
issn = "0300-9084",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Metabolic effects of anti-angiogenic therapy in tumors

AU - Zulato, Elisabetta

AU - Curtarello, Matteo

AU - Nardo, Giorgia

AU - Indraccolo, Stefano

PY - 2012/4

Y1 - 2012/4

N2 - Anti-angiogenic therapy has recently been added to the panel of cancer therapeutics, but predictive biomarkers of response are still not available. In animal models, anti-angiogenic therapy causes tumor starvation by increasing hypoxia and impairing nutrients supply. It is thus conceivable that angiogenesis inhibition causes remarkable metabolic perturbations in tumors, although they remain largely uncharted. We review here recent acquisitions about metabolic effects of angiogenesis blockade in tumors and discuss the possibility that some metabolic features of tumor cells - i.e. their dependency from glucose as primary energy substrate - might affect tumor responses to anti-VEGF treatment.

AB - Anti-angiogenic therapy has recently been added to the panel of cancer therapeutics, but predictive biomarkers of response are still not available. In animal models, anti-angiogenic therapy causes tumor starvation by increasing hypoxia and impairing nutrients supply. It is thus conceivable that angiogenesis inhibition causes remarkable metabolic perturbations in tumors, although they remain largely uncharted. We review here recent acquisitions about metabolic effects of angiogenesis blockade in tumors and discuss the possibility that some metabolic features of tumor cells - i.e. their dependency from glucose as primary energy substrate - might affect tumor responses to anti-VEGF treatment.

KW - Angiogenesis

KW - Anti-angiogenic therapy

KW - Glycolysis

KW - LKB1-AMPK pathway

UR - http://www.scopus.com/inward/record.url?scp=84857450316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857450316&partnerID=8YFLogxK

U2 - 10.1016/j.biochi.2012.01.001

DO - 10.1016/j.biochi.2012.01.001

M3 - Article

C2 - 22245704

AN - SCOPUS:84857450316

VL - 94

SP - 925

EP - 931

JO - Biochimie

JF - Biochimie

SN - 0300-9084

IS - 4

ER -